Outcomes of salvage lung resections in advanced EGFR ‐mutant lung adenocarcinomas under EGFR TKIs-Reference-Cited by-同舟云学术

Outcomes of salvage lung resections in advanced EGFR ‐mutant lung adenocarcinomas under EGFR TKIs

Published:2021-09-08 Issue:20 Volume:12 Page:2655-2665
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Chen Ying‐Yuan¹²,Yen Yi‐Ting¹,Lai Wu‐Wei¹,Huang Wei‐Li¹²,Chang Chao‐Chun¹,Tseng Yau‐Lin¹^ORCID

Affiliation:

1. Division of Thoracic Surgery, Department of Surgery National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan

2. Institute of Clinical Medicine, College of Medicine, National Cheng Kung University Tainan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13646

Reference38 articles.

1. Global cancer statistics, 2012

2. Comprehensive molecular profiling of lung adenocarcinoma

3. A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

4. Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)

5. Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage surgery following tyrosine kinase inhibitor treatment for advanced non-small cell lung cancer;Surgical Case Reports;2024-06-20

2. Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery;Surgery Today;2024-03-14

3. A case of salvage surgery for rapidly growing lesions during treatment with afatinib in a patient with postoperative recurrence of bilateral multiple lung cancer;The Journal of the Japanese Association for Chest Surgery;2024-01-15

4. Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations for advanced lung adenocarcinoma;World Journal of Surgical Oncology;2023-10-13

5. Achievement of pathological complete response with osimertinib for EGFR-mutated lung adenocarcinoma;General Thoracic and Cardiovascular Surgery Cases;2023-09-21